Mimedx Group Inc (MDXG) financials
Mimedx Group revenue and earnings by year
Mimedx Group's revenue was $419 million in the fiscal year to December 31, 2025, up 20.0% from the year before. Net income was $48.6 million, 11.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 6.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 419 | 349 | 321 | 268 | 242 | 248 | 299 | 359 | 321 | 245 |
| Revenue growth | 20.0% | 8.5% | 20.0% | 10.7% | -2.5% | -17.0% | -16.7% | 11.8% | 31.1% | — |
| Gross profit | 346 | 289 | 267 | 220 | 202 | 209 | 256 | 323 | 286 | 213 |
| Gross margin | 82.6% | 82.8% | 83.0% | 82.0% | 83.6% | 84.2% | 85.6% | 89.9% | 89.0% | 86.8% |
| Operating income | 64 | 59 | 37 | -15 | -7 | -45 | -21 | -4 | 46 | 18 |
| Operating margin | 15.3% | 16.9% | 11.5% | -5.5% | -2.9% | -18.3% | -7.1% | -1.1% | 14.4% | 7.4% |
| Net income | 49 | 42 | 58 | -30 | -10 | -83 | -26 | -30 | 65 | 12 |
| Net margin | 11.6% | 12.2% | 18.1% | -11.3% | -4.2% | -33.6% | -8.5% | -8.3% | 20.2% | 4.9% |
| Diluted EPS | $0.32 | $0.28 | $0.37 | -$0.33 | — | -$0.77 | -$0.24 | -$0.28 | $0.55 | $0.11 |
| Free cash flow | 73 | 65 | 25 | -19 | -5 | -34 | -41 | 26 | 58 | 20 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open MDXG in Markets.
How Mimedx Group makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Surgical | $40.0M | 64.2% |
| Wound | $22.3M | 35.8% |
See also: MDXG valuation and P/E history · MDXG returns
No forecast, no recommendation. This page describes Mimedx Group Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.